 Purification characterization inhibitor soluble tumor necrosis factor receptor tumor necrosis factor lymphotoxin serum ultrafiltrates human cancer patients Serum SUF human patients different types cancer blocking factor BF cytolytic activity human tumor necrosis factor alpha TNF-alpha vitro BF protein molecular mass kDa sodium dodecyl sulfate/polyacrylamide gel electrophoresis SDS/PAGE active material homogeneity combination affinity chromatography PAGE high-pressure liquid chromatography Amino acid sequence analysis BF membrane TNF receptor Purified BF lytic activity recombinant human TNF-alpha recombinant human lymphotoxin murine cells vitro BF lytic activity TNF-alpha lymphotoxin BF necrotizing activity recombinant human TNF-alpha cutaneous Meth tumors BALB/c mice BF important role regulation control TNF-alpha lymphotoxin activity cancer patients ii interaction tumor host antitumor mechanisms iii use TNF-alpha clinical trials human cancer patients